Ultrahuman

Last updated
Ultrahuman Healthcare
Founder
  • Mohit Kumar
  • Vatsal Singhal
HeadquartersLondon, UK

Bengaluru, India

Abu Dhabi, UAE
Products
  • Ultrahuman Ring
  • Ultrahuman M1
Number of employees
51-200

Ultrahuman is a Bengaluru based longevity and health-monitoring platform that designs, manufactures and sells the Ultrahuman Ring Air health tracker, Ultrahuman M1 Continuous glucose monitor, pre-release Ultrahuman Home health monitor and related blood testing services like Blood vision. Ultrahuman was incorporated in 2019 by second time entrepreneurs Mohit Kumar and Vatsal Singhal. Mohit and Vatsal also co-founded RoadRunnr in the year 2015. RoadRunnr later merged with Zomato [1] and eventually became Zomato Food delivery. Zomato went public at $15bn in market value in 2021.

Contents

History

Ultrahuman was founded by Mohit Kumar and Vatsal Singhal in 2019. [2]

Mohit Kumar, post his stint at Zomato, took a break to study martial arts at Tiger Muay Thai in Thailand. He initially observed athletes using biomarker data across streams such as glucose, HRV, blood markers etc and started designing a platform that the athletes could use to see all the data in one place. In January 2021, Ultrahuman launched its app at CES [3] in Los Angeles and Won the 'Best of CES award'. In June 2021, it launched a continuous glucose monitor called Ultrahuman M1 (formerly known as Ultrahuman Cyborg). [4]

In April 2022, Ultrahuman acquired LazyCo - a wearables IOT company. [5] LazyCo built hardware products like an AI-powered smart ring designed to predict and automate daily tasks. [6] [7] [8]

In June 2023, Ultrahuman won the Red Dot award at Berlin for its flagship Ultrahuman Ring Air. Ultrahuman has also raised 3 rounds of investments in the year 2020, 2022 and 2024 totalling up to $65 million. Ultrahuman claims to be EBITDA profitable and has declared its IPO plans for 2026.

Research and patents

Ultrahuman conducted a multi-armed observational study [9] which included 105 non-diabetic and pre-diabetic individuals. It aimed to show metabolic health as a continuous spectrum between non-diabetic and diabetic individuals. The clinical trial showed a correlation between its health score 'Metabolic score' and inflammation in the body. The trial also included blood markers and gut-microbiome index markers.

The research got published in Nature , [9] and generated controversy due to the inclusion of non-diabetic individuals in the trial.[ citation needed ]

Ultrahuman claims to have a global patent on the ring design and the charger along with 150 odd trademarks. Notably, it is fighting a patent litigation with the Finnish wearables company Oura ring.[ citation needed ]

Funding

Ultrahuman has raised $65 million across three rounds of investments.

Ultrahuman raised $7.5 mn in Seed round from Nexus Venture partners and Blume ventures. [10]

In their Series A round, [11] Ultrahuman raised $17.5M in funding from Alpha Wave Incubation (AWI), [12] [13] Steadview Capital, Nexus Venture Partners, Blume Ventures and iSeed fund.

Balaji Srinivasan (ex-Coinbase), Nithin Kamath (founder of Zerodha via Rainmatter), Kunal Shah (founder of CRED), Preethi Kasireddy (ex-a16z), Akshay BD (founding team Uber India), RazorPay founders and Tanmay Bhat (celebrity content creator and investor) along with several others, have invested in Ultrahuman. [14] [15] [16]

UltraFactory

Ultrahuman launched its first design and manufacturing facility in Bengaluru, India called 'UltraFactory' in the year 2022. The factory claimed to have the capacity to manufacture 10,000 devices monthly. Ultrahuman announced in 2024 that it has extended the UltraFactory to grow by 7x in capacity. [17]

Related Research Articles

<span class="mw-page-title-main">Glucose</span> Naturally produced monosaccharide

Glucose is a sugar with the molecular formula C6H12O6. Glucose is overall the most abundant monosaccharide, a subcategory of carbohydrates. Glucose is mainly made by plants and most algae during photosynthesis from water and carbon dioxide, using energy from sunlight, where it is used to make cellulose in cell walls, the most abundant carbohydrate in the world or, ATP(Adenosine Triphosphate) which is used by the cell as energy.

<span class="mw-page-title-main">Hypoglycemia</span> Health condition

Hypoglycemia, also called low blood sugar, is a fall in blood sugar to levels below normal, typically below 70 mg/dL (3.9 mmol/L). Whipple's triad is used to properly identify hypoglycemic episodes. It is defined as blood glucose below 70 mg/dL (3.9 mmol/L), symptoms associated with hypoglycemia, and resolution of symptoms when blood sugar returns to normal. Hypoglycemia may result in headache, tiredness, clumsiness, trouble talking, confusion, fast heart rate, sweating, shakiness, nervousness, hunger, loss of consciousness, seizures, or death. Symptoms typically come on quickly.

The following is a glossary of diabetes which explains terms connected with diabetes.

<span class="mw-page-title-main">Diabetic ketoacidosis</span> Medical condition

Diabetic ketoacidosis (DKA) is a potentially life-threatening complication of diabetes mellitus. Signs and symptoms may include vomiting, abdominal pain, deep gasping breathing, increased urination, weakness, confusion and occasionally loss of consciousness. A person's breath may develop a specific "fruity" smell. The onset of symptoms is usually rapid. People without a previous diagnosis of diabetes may develop DKA as the first obvious symptom.

<span class="mw-page-title-main">Blood glucose monitoring</span> Use of a glucose monitor for testing the concentration of glucose in the blood

Blood glucose monitoring is the use of a glucose meter for testing the concentration of glucose in the blood (glycemia). Particularly important in diabetes management, a blood glucose test is typically performed by piercing the skin to draw blood, then applying the blood to a chemically active disposable 'test-strip'. The other main option is continuous glucose monitoring (CGM). Different manufacturers use different technology, but most systems measure an electrical characteristic and use this to determine the glucose level in the blood. Skin-prick methods measure capillary blood glucose, whereas CGM correlates interstitial fluid glucose level to blood glucose level. Measurements may occur after fasting or at random nonfasting intervals, each of which informs diagnosis or monitoring in different ways.

<span class="mw-page-title-main">Hyperglycemia</span> Too much blood sugar, usually because of diabetes

Hyperglycemia is a condition in which an excessive amount of glucose circulates in the blood plasma. This is generally a blood sugar level higher than 11.1 mmol/L (200 mg/dL), but symptoms may not start to become noticeable until even higher values such as 13.9–16.7 mmol/L (~250–300 mg/dL). A subject with a consistent fasting blood glucose range between ~5.6 and ~7 mmol/L is considered slightly hyperglycemic, and above 7 mmol/L is generally held to have diabetes. For diabetics, glucose levels that are considered to be too hyperglycemic can vary from person to person, mainly due to the person's renal threshold of glucose and overall glucose tolerance. On average, however, chronic levels above 10–12 mmol/L (180–216 mg/dL) can produce noticeable organ damage over time.

<span class="mw-page-title-main">Type 2 diabetes</span> Type of diabetes mellitus with high blood sugar and insulin resistance

Type 2 diabetes (T2D), formerly known as adult-onset diabetes, is a form of diabetes mellitus that is characterized by high blood sugar, insulin resistance, and relative lack of insulin. Common symptoms include increased thirst, frequent urination, fatigue and unexplained weight loss. Symptoms may also include increased hunger, having a sensation of pins and needles, and sores (wounds) that do not heal. Often symptoms come on slowly. Long-term complications from high blood sugar include heart disease, stroke, diabetic retinopathy which can result in blindness, kidney failure, and poor blood flow in the limbs which may lead to amputations. The sudden onset of hyperosmolar hyperglycemic state may occur; however, ketoacidosis is uncommon.

<span class="mw-page-title-main">Blood sugar level</span> Concentration of glucose present in the blood (Glycaemia)

The blood sugar level, blood sugar concentration, blood glucose level, or glycemia is the measure of glucose concentrated in the blood. The body tightly regulates blood glucose levels as a part of metabolic homeostasis.

<span class="mw-page-title-main">Hypophosphatemia</span> Lack of phosphate in the blood

Hypophosphatemia is an electrolyte disorder in which there is a low level of phosphate in the blood. Symptoms may include weakness, trouble breathing, and loss of appetite. Complications may include seizures, coma, rhabdomyolysis, or softening of the bones.

Glycated hemoglobin, also known as HbA1c, glycohemoglobin, glycosylated hemoglobin, or simply A1c, is a form of hemoglobin (Hb) that is chemically linked to a sugar. Most monosaccharides, including glucose, galactose and fructose, spontaneously bond with hemoglobin when present in the bloodstream. However, glucose is only 21% as likely to do so as galactose and 13% as likely to do so as fructose, which may explain why glucose is used as the primary metabolic fuel in humans.

The term diabetes includes several different metabolic disorders that all, if left untreated, result in abnormally high concentrations of a sugar called glucose in the blood. Diabetes mellitus type 1 results when the pancreas no longer produces significant amounts of the hormone insulin, usually owing to the autoimmune destruction of the insulin-producing beta cells of the pancreas. Diabetes mellitus type 2, in contrast, is now thought to result from autoimmune attacks on the pancreas and/or insulin resistance. The pancreas of a person with type 2 diabetes may be producing normal or even abnormally large amounts of insulin. Other forms of diabetes mellitus, such as the various forms of maturity-onset diabetes of the young, may represent some combination of insufficient insulin production and insulin resistance. Some degree of insulin resistance may also be present in a person with type 1 diabetes.

<span class="mw-page-title-main">Ketonuria</span> Medical condition

Ketonuria is a medical condition in which ketone bodies are present in the urine.

<span class="mw-page-title-main">Elliott P. Joslin</span> American physician

Elliott Proctor Joslin was the first medical doctor in the United States to specialize in diabetes and was the founder of the present-day Joslin Diabetes Center in Boston, Massachusetts.

<span class="mw-page-title-main">Comprehensive metabolic panel</span> Blood test assessing vital organ health

The comprehensive metabolic panel, or chemical screen, is a panel of 14 blood tests that serves as an initial broad medical screening tool. The CMP provides a rough check of kidney function, liver function, diabetic and parathyroid status, and electrolyte and fluid balance, but this type of screening has its limitations. Abnormal values from a CMP are often the result of false positives and thus the CMP may need to be repeated, requiring a second blood drawing procedure and possibly additional expense for the patient, even though no disease is present. This test is also known as SMA12+2 test.

DexCom, Inc. is a company that develops, manufactures, produces, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has manufacturing facilities in Mesa, Arizona and Batu Kawan, Malaysia.

Researcher - Dr. Dinesh Kacha Research Article - Diabetes Reversal Through Ayurvedic Lifestyle

Empagliflozin, sold under the brand name Jardiance, among others, is an antidiabetic medication used to improve glucose control in people with type 2 diabetes. It is taken by mouth.

<span class="mw-page-title-main">Diabetes</span> Group of endocrine diseases characterized by high blood sugar levels

Diabetes mellitus, often known simply as diabetes, is a group of common endocrine diseases characterized by sustained high blood sugar levels. Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body becoming unresponsive to the hormone's effects. Classic symptoms include thirst, polyuria, weight loss, and blurred vision. If left untreated, the disease can lead to various health complications, including disorders of the cardiovascular system, eye, kidney, and nerves. Diabetes accounts for approximately 4.2 million deaths every year, with an estimated 1.5 million caused by either untreated or poorly treated diabetes.

<span class="mw-page-title-main">Continuous glucose monitor</span> Blood glucose monitoring device

A continuous glucose monitor (CGM) is a device used for monitoring blood glucose on a continual basis instead of monitoring glucose levels periodically by drawing a drop of blood from a finger. This is known as continuous glucose monitoring. CGMs are used by people who treat their diabetes with insulin, for example people with type 1 diabetes, type 2 diabetes, or other types of diabetes, such as gestational diabetes.

Info Edge is an Indian technology holding company which owns, operates and invests in internet-led businesses. The company's offerings include the flagship employment website Naukri.com, matrimonial website Jeevansathi.com, real estate classifieds platform 99Acres.com, and educational portal Shiksha.com, among others. As of 2018, more than 70 percent of the company's revenue came from Naukri.com.

References

  1. Sen, Anirban (2017-09-13). "Zomato acquires food delivery start-up Runnr". mint. Retrieved 2024-03-22.
  2. "Ultrahuman's Mohit Kumar bets big on wearables". Mintlounge. 2022-10-28. Retrieved 2023-02-13.
  3. Ultrahuman. "Ultrahuman Launches At CES". www.prnewswire.com (Press release). Retrieved 2022-12-29.
  4. "Ultrahuman makes the platform more accessible by coming out of private beta". Suger Mint. 2022-09-27. Retrieved 2023-02-13.
  5. "Lazy Co". Gust. Retrieved 2023-02-13.
  6. "Metabolic fitness platform Ultrahuman acquires LazyCo". The Times of India. 2022-04-12. ISSN   0971-8257 . Retrieved 2023-02-13.
  7. "Healthtech startup Ultrahuman acquires wearables firm LazyCo". The Economic Times. 2022-04-12. ISSN   0013-0389 . Retrieved 2023-02-13.
  8. "Metabolic fitness platform Ultrahuman acquires LazyCo". Moneycontrol. 12 April 2022. Retrieved 2023-02-13.
  9. 1 2 Chaudhry, Monik; Kumar, Mohit; Singhal, Vatsal; Srinivasan, Bhuvan (18 March 2024). "Metabolic health tracking using Ultrahuman M1 continuous glucose monitoring platform in non- and pre-diabetic Indians: a multi-armed observational study". Scientific Reports. 14 (1): 6490. Bibcode:2024NatSR..14.6490C. doi:10.1038/s41598-024-56933-2. PMC   10948749 . PMID   38499685.
  10. "Ultrahuman company information, funding & investors". app.dealroom.co. 2020-11-01. Retrieved 2024-06-14.
  11. Lomas, Natasha (2021-08-17). "Ultrahuman raises $17.5M, touting a wearable blood glucose tracker". TechCrunch. Retrieved 2024-06-14.
  12. Prosser, David. "How Ultrahuman Is Moving From Sports Science To Global Healthcare". Forbes. Retrieved 2023-02-13.
  13. "Alpha Wave Ventures and Alpha Wave Incubation Companies". www.alphawaveglobal.com. Retrieved 2023-02-13.
  14. PTI (2021-08-17). "Healthtech wearable glucose tracker Ultrahuman raises $17.5 million". The Hindu. ISSN   0971-751X . Retrieved 2023-02-13.
  15. Reporter, B. S. (2021-08-17). "Healthtech startup Ultrahuman raises $17.5m in Series B funding round". www.business-standard.com. Retrieved 2023-02-13.
  16. Pillai, Anvita (2021-08-16). "Metabolic Fitness Platform Ultrahuman Raises $17.5 Mn In Series B Funding". Inc42 Media. Retrieved 2023-02-13.
  17. Lomas, Natasha (2024-03-20). "Smart ring maker Ultrahuman has its eye on Oura's crown". TechCrunch. Retrieved 2024-03-22.